Non-specific immunostimulation in bronchogenic cancer.
D000230:Adenocarcinoma / Q000276:immunology / Q000401:mortality; D000917:Antibody Formation; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D002283:Carcinoma, Bronchogenic / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D018288:Carcinoma, Small Cell / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D003352:Corynebacterium; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D007958:Leukocyte Count; D008175:Lung Neoplasms / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D010587:Phagocytosis; D011379:Prognosis; D011425:Propionibacterium acnes; D012882:Skin Tests
D000970:Antineoplastic Agents; D001428:Bacterial Vaccines